Actimmune: Phase II

In a 70-patient U.S. and Canadian Phase II trial, ITMN said

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE